Procurement Summary
Country : Canada
Summary : Rfp Standard Dose Annual Influenza Vaccine
Deadline : 05 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 114882622
Document Ref. No. : WS5019923196
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Canada is seeking offers for the supply of Trivalent Annual Influenza Vaccine, duly authorized for sale in Canada. The period of the contract is from award to March 31, 2026.
Solicitation Type : RFP - Request for Proposal (Formal)
Reference Number : WS5019923196-Doc5022250612
Location : Nova Scotia
: Northwest Territories
: British Columbia
: Yukon
: Ontario
: Newfoundland and Labrador
: Manitoba
: Alberta
: New Brunswick
: Prince Edward Island
: Quebec
: National Capital Region
: Saskatchewan
: Nunavut
Dates Publication : 2025/02/14 12:00:00 AM EST
Closing Date : 2025/03/05 02:00:00 PM EST
Contact Information : Baird, Christa (SPAC/PSPC)
: christa.baird@tpsgc-pwgsc.gc.ca
Description : Canada is seeking offers for the supply of Trivalent Annual Influenza Vaccine, duly authorized for sale in Canada. The period of the contract is from award to March 31, 2026.
Documents
Tender Notice